12:00 AM
 | 
Sep 20, 1999
 |  BC Week In Review  |  Company News  |  Other News

Kennedy Krieger Institute other research news

Kennedy researchers published in the Journal of the National Cancer Institute that its synthetic U1-ribozymes reduced the ability...

Read the full 70 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >